Medtech Companies in Flowable Hemostats Market Cement Supply Chains to Ensure Access to Advanced Hemostatis for Surgeries, Valuation to Reach US$1 Bn by 2027: TMR

- Healthcare companies harness hemostat technologies to improve surgical outcomes in orthopedics and cardiology, thrombin-gelatin hemostatic matrix gathers traction due to remarkable safety and efficacy

- Tranexamic acid-loaded starch microspheres and novel hemostatic agents such as flowable procoagulants attract R&D interest, stringent regulations in key economies shape the contours of growth in flowable hemostats markets

ALBANY, N.Y., Jan. 21, 2021 /PRNewswire/ -- Flowable hemostats are gaining popularity in clinical practice to meet the need of advanced hemostatis. They reduce time to hemostatis, stop preoperative bleeding, and reduce the rate of postoperative bleeding.

The sales in the flowable hemostats market has risen due the widespread application of these in general surgeries. In particular, a variety of novel hemostatic agents such as hemostats and sealants find use in cardiovascular surgeries, endoscopic sinus surgeries, and hepatic surgeries. These agents may contain either bovine or porcine gelatin as one of the passive elements. Some of the product categories in the flowable hemostats market that exhibit vast clinical promise are tranexamic acid-loaded starch microspheres and thrombin-gelatin hemostatic matrix.

The valuation in the global flowable hemostats market was pegged at US$ 700 Mn in 2018, and is anticipated to reach worth of US$1 bn by 2027-end.

Request for Analysis of COVID-19 Impact on Flowable Hemostats Market – https://www.transparencymarketresearch.com/covid19.php

Analysts at TMR concur that in recent months, medical technology companies in the flowable hemostats market are consolidating their production capabilities to develop hemostats used in vascular surgeries.

Key Findings of Flowable Hemostats Market

Demand during Covid-19 Pandemic Nudge Companies toward Robust Supply Chain

The Covid-19 pandemic that engulfed the healthcare systems worldwide has put marked pressure on manufacturers and healthcare providers to ensure adequate supply of advanced hemostatic agents. This has motivated healthcare and medical technology companies to strengthen their production and supply chains. Surgeons in recent months have benefitted from stocked inventory to cater to surge in demand for advanced hemostatic devices and agents. To this end, companies are keenly consolidating their supply chain with the aid of strategic partnerships and distribution agreements in various geographies. Meanwhile, medtech companies are relentlessly researching on novel techniques of applying hemostatic agents.

Request Brochure of Flowable Hemostats Market Report - https://www.transparencymarketresearch.com/brochure.php

Difficult-to-access Bleeding Sites See Advent of Novel Agents

The demand for hemostatic agents to achieve hemostatis in preoperative settings is crucial, especially in general surgeries. In this regard, the use of thrombin-gelatin hemostatic matrix in devices has gained traction in the flowable hemostats market. New agents with remarkable safety and efficacy profiles are actively being pursued by healthcare industries, especially to meet the needs of cardiology and orthopedics. Drug-loaded materials have gained clinical acceptance due to their higher performance. In recent years, drug-loaded materials are attracting the interest of medical technology companies who are keen on unveiling next-gen hemostats, such as for use at vascular access sites and percutaneous sites. Further, the opportunities in the flowable hemostats market benefit on back of growing awareness about the adverse effects of hemostatis, thus warranting use of these in only clinically proven conditions. 

Purchase the Flowable Hemostats Market Report - https://www.transparencymarketresearch.com/checkout.php

Stringent Regulations in Key Markets Spur Use of Clinically Proven

North America has been one of the remarkably lucrative regions in the global flowable hemostats market. A promising demographics and presence of large target population, such as those with traumatic injuries, drive the appetite for next-gen devices. In this regard, federal regulations have nudged manufacturers and healthcare companies to market only those hemostatic devices that are clinically proven to meet the objective.

Request for Custom Research - https://www.transparencymarketresearch.com/custom-research.php

Flowable Hemostats Market: Key Driving Factors and Promising Avenues

• Rise in geriatric population a promising demographic trend in the flowable hemostats market.
• Rise in hospitalization for surgeries due to traumatic injuries is propelling the demand for advanced hemostatis.
• Rise in cardiac and orthopedic procedures and general surgeries is a key trend boosting the growth of the flowable hemostat market. A part of this has to do with high prevalence of cardiovascular diseases.
• Research on novel hemostat agents to expand the revenue potential of key industry stakeholders.

Flowable Hemostats Market: Competitive Dynamics

• The presence of small number of players make the global flowable hemostats market increasingly consolidated.
• Well-entrenched players include Teleflex Incorporated, Baxter International, Inc., and Johnson & Johnson.
• New entrants and incumbent players set their sights on Asia Pacific to tap into large revenue stream

Explore Transparency Market Research's award-winning coverage of the global Healthcare Industry:

Vascular Closure Devices Market: https://www.transparencymarketresearch.com/vascular-closure-devices-market.html

Gastrointestinal Bleeding Treatment Market: https://www.transparencymarketresearch.com/gastrointestinal-bleeding-treatment-market.html

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision."

Browse More Upcoming Reports by Transparency Market Research: https://www.transparencymarketresearch.com/upcoming.htm

Contact

Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com 
Press Release Source: https://www.transparencymarketresearch.com/pressrelease/flowable-hemostats-market.htm 
Website: https://www.transparencymarketresearch.com/

Logo: https://mma.prnewswire.com/media/1085206/Transparency_Market_Research_Logo.jpg